| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |